Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.Frontiers in Cell and Developmental Biology|May 3, 2021
High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary CellsDi Cui, Alexandra Franz, Sophie A Fillon, et al.Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.Glycobiology|June 6, 2020
Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expressionGavuthami Murugesan, Viviana G Correia, Angelina S Palma, et al.Biochemical and Biophysical Research Communications|August 22, 2018
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodiesSathyadevi Venkataramani, Sarah Low, Bernd Weigle, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicityMarc Schmitz, Senming Zhao, Yvonne Deuse, et al.International Journal of Molecular Sciences|November 27, 2024
Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis ToolsJohanna B Brüggenthies, Jakob Dittmer, Eva Martin, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)Ralf G Meyer, Cedrik M Britten, Ulrike Siepmann, et al.Pageof 4